AzTrials
AzTrials

Eating DisordersNCT07807774

FlexED: National Substudy

A study testing FlexED in people with Eating Disorders and Body Image, run by Duke University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to test the feasibility of disseminating an intervention broadly. "FlexED" is a digital gamified intervention targeting eating disorder symptoms in young women and girls at risk by changing how they experience thoughts and feelings about their body. Read more about this study

Who is it for?
Ages 18 to 25 years
Conditions the study is for
Eating Disorders, Body Image
What is being tested?
FlexED
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
24 Aug 2026to 31 Jul 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Female between the age of 18-25 years old.

Who cannot join

  • Non-English speaking

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Dottie R Mayo contact

919-668-1935

drm72@duke.edu

United States1 site, 1 recruiting
  • Duke University Medical Center

    Durham, North Carolina, 27705

    Dottie R Mayo, 919-668-1935, drm72@duke.edu

    Rhonda M Merwin, PhD

    Recruiting

Other trials in United States

About this study

Official title: FlexED: A Digital Gamified Early Intervention for Eating Disorders

The purpose of this study is to test the feasibility of disseminating an intervention broadly. "FlexED" is a digital gamified intervention targeting eating disorder symptoms in young women and girls at risk by changing how they experience thoughts and feelings about their body. The digital intervention is based on Acceptance and Commitment Therapy (ACT).

Participants complete seven 20-minute sessions of the intervention using their smartphone over about 8 weeks. Participants also complete questionnaires bi-weekly as they go through the intervention. A final measurement is taken one month after the last digital intervention session. These surveys are all conducted online. Participants are in the study for up to 12 weeks.

Being tested
FlexED
Keywords
Body Image Flexibility, Eating Disorders, Acceptance and Commitment Therapy, Psychological Flexibility, Early Intervention
Medical subject headings
Feeding and Eating Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FlexEDBehavioural

    Intervention consists of seven 20-minute sessions of a digital intervention based on Acceptance and Commitment Therapy (ACT). Participants learn psychological flexibility skills for body-image distress by completing interactive exercises and games with a relatable character and story line and receive rewards that reinforce learning.

Study groups in NCT07807774
Study groupRoleWhat they receive
FlexEDExperimentalSeven 20-minute sessions of an online, multimedia application that teaches psychological flexibility with body-image related thoughts and feelings.
Receives: Behavioral: FlexED

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in the Body Image - Acceptance and Action Questionnaire (BI-AAQ)-5

    Self-report measure of body-image psychological flexibility. The measure consists of 5 items that ask about the degree to which thoughts and feelings about the body interfere with living. Scores range from 5-35, with higher scores indicating greater flexibility/adaptability.

    Measured: Baseline, Week 4, Week 8, Week 12

  2. Change from Baseline in the Comprehensive Assessment of Acceptance and Commitment Therapy Processes -10 (CompACT-10)

    A 10-item measure of psychological flexibility as a multidimensional construct with subscales of Openness, Awareness and Engagement. Openness scores range from 0-18, Awareness 0-18, and Engagement 0-24. Higher scores indicate greater flexibility/adaptability.

    Measured: Baseline, Week 4, Week 8, Week 12

  3. Change in Weight Concern Scale Score

    5-item measure of weight concerns (worry about weight, fear of weight gain, dieting history, importance of weight, fear of fatness). Scores range from 0-100, with elevated scores (scores >= 47) having been associated with an increased risk of developing an eating disorder.

    Measured: Baseline, Week 8, Week 12

  4. Change from Baseline in the Eating Disorder Examination Questionnaire - Short (EDE-QS)

    Short questionnaire format (12 items) of the clinician-administered interview assessing eating disorder symptom severity. Scores range from 0-36, with higher scores indicating greater symptomatology.

    Measured: Baseline, Week 8, Week 12

  5. Acceptability of the Intervention

    Session completion rates

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2026
  2. Study start24 Aug 2026
  3. Primary completion15 Jul 2028 (estimated)
  4. Study completion31 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07807774
Sponsor's protocol ID
Pro00111571_2
Other IDs
4R33MH127137-03
Status last verified
Sep 2026
First submitted
2 Sep 2026
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data and data dictionaries will be made available at the time of publication.

Questions about this trial

What is this clinical trial studying?

A study testing FlexED in people with Eating Disorders and Body Image, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dottie R Mayo (919-668-1935, drm72@duke.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in the Body Image - Acceptance and Action Questionnaire (BI-AAQ)-5 (time frame: Baseline, Week 4, Week 8, Week 12). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in